CRIS Current Research Information System

BAIARDI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.838
NA - Nord America 4.875
EU - Europa 3.101
SA - Sud America 354
AF - Africa 192
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.758
SG - Singapore 1.632
VN - Vietnam 1.399
CN - Cina 1.369
IT - Italia 1.141
HK - Hong Kong 422
GB - Regno Unito 393
DE - Germania 325
KR - Corea 244
SE - Svezia 236
BR - Brasile 232
FR - Francia 188
IN - India 183
NL - Olanda 180
BD - Bangladesh 165
RU - Federazione Russa 124
FI - Finlandia 113
IE - Irlanda 112
JP - Giappone 100
CA - Canada 64
ID - Indonesia 60
SC - Seychelles 56
AR - Argentina 46
ZA - Sudafrica 45
CI - Costa d'Avorio 43
BG - Bulgaria 42
MX - Messico 36
TR - Turchia 35
UA - Ucraina 35
DK - Danimarca 32
TH - Thailandia 30
IQ - Iraq 29
JO - Giordania 29
PH - Filippine 29
AT - Austria 27
EC - Ecuador 25
ES - Italia 24
EE - Estonia 22
PL - Polonia 21
TW - Taiwan 19
PK - Pakistan 18
CH - Svizzera 16
CO - Colombia 15
BE - Belgio 14
VE - Venezuela 14
SA - Arabia Saudita 11
UZ - Uzbekistan 11
IL - Israele 9
AU - Australia 8
CL - Cile 8
MA - Marocco 8
MY - Malesia 8
TG - Togo 7
CZ - Repubblica Ceca 6
GR - Grecia 6
LT - Lituania 6
MD - Moldavia 6
PY - Paraguay 6
TN - Tunisia 6
DZ - Algeria 5
DO - Repubblica Dominicana 4
EG - Egitto 4
HR - Croazia 4
KH - Cambogia 4
LB - Libano 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IR - Iran 3
LU - Lussemburgo 3
LV - Lettonia 3
RO - Romania 3
BS - Bahamas 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
PE - Perù 2
SV - El Salvador 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
GF - Guiana Francese 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
Totale 14.350
Salva come PNG Salva come JPEG
Città #
Singapore 1.183
Ashburn 587
Hefei 494
Hong Kong 403
Fairfield 359
Ho Chi Minh City 307
Southend 300
Chandler 289
San Jose 279
Hanoi 276
Bologna 272
Dallas 235
Seoul 222
Dong Ket 187
Woodbridge 173
Seattle 157
Houston 149
Beijing 137
Cambridge 131
Wilmington 131
Santa Clara 129
Council Bluffs 128
Boardman 118
Dublin 112
Princeton 104
Redmond 96
Ann Arbor 95
Los Angeles 95
New York 88
Lauterbourg 82
Tokyo 80
Turin 79
Milan 64
Helsinki 61
Bengaluru 52
Redondo Beach 52
Frankfurt am Main 46
Lappeenranta 45
Florence 44
Abidjan 43
Berlin 43
Haiphong 43
Buffalo 41
Sofia 40
Da Nang 38
Jakarta 37
Chicago 36
Rome 34
Westminster 34
Imola 31
Amman 29
Nanjing 28
Nuremberg 27
São Paulo 26
Guangzhou 24
Phoenix 24
Jinan 22
Amsterdam 21
Copenhagen 21
Boydton 20
Can Tho 20
Montreal 20
Padova 20
Rimini 20
London 19
Mexico City 19
Shanghai 19
San Francisco 18
Verona 17
Biên Hòa 16
Hải Dương 16
San Diego 16
Toronto 16
Vienna 16
Falkenstein 15
Changsha 14
Tianjin 14
Brussels 13
Des Moines 13
Falls Church 13
Istanbul 13
Shenyang 13
Tongling 13
Warsaw 13
Forlì 11
Munich 11
Naples 11
Orem 11
Quito 11
Stockholm 11
Atlanta 10
Charlotte 10
Genoa 10
Hangzhou 10
The Dalles 10
Thái Bình 10
Thái Nguyên 10
Xi'an 10
Yubileyny 10
Baghdad 9
Totale 9.054
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 415
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 285
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 262
Chronobiology, sleep-related risk factors and light therapy in perinatal depression: The "Life-ON" project 252
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 252
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 225
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 225
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 223
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 221
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 207
A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome. 203
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 199
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 195
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 195
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 195
Clinical effects of Lewy body pathology in cognitively impaired individuals 193
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 187
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 185
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 182
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 181
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 180
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 176
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 173
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 173
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 172
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 171
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 168
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 168
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 167
Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study 167
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 163
Is the Epworth Sleepiness Scale a useful tool for screening excessive daytime sleepiness in commercial drivers? 162
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 160
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 158
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 158
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 157
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 157
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 155
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 155
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 155
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 153
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 152
Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type 151
Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease 151
Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases 149
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 149
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 148
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 146
Depressive Symptoms and Amyloid Pathology 143
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? 141
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC 139
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies 138
Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at PRNP Codon 129 136
Survival of dialysis patients with restless legs syndrome: A 15-year follow-up study 133
Cognitive effects of Lewy body pathology in clinically unimpaired individuals 132
Sleep-readiness signals in insomniacs and good sleepers 131
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies 130
Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy 129
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorder 128
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease 128
Influence of chronotype on the incidence and severity of perinatal depression in the "Life-ON" study 127
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 127
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease 126
Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies 124
Recent advances in the histo-molecular pathology of human prion disease 124
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias 123
Understanding prion strains: Evidence from studies of the disease forms affecting humans 123
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease 122
Remitting Tics and Narcolepsy Overlap Associated with Streptococcal Infection: A Case Report 117
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease 117
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease 116
Csf ubiquitin levels are higher in alzheimer’s disease than in frontotemporal dementia and reflect the molecular subtype in prion disease 115
On the road for a single and reliable objective assessment of sleepiness. 113
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 112
Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature 106
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 104
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease 103
null 103
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia 102
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification 100
Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience 100
null 96
The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases 95
Gerstmann-Straüssler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism 95
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis 87
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 81
Technique and Preliminary Analysis of Drug-Induced Sleep Endoscopy With Online Polygraphic Cardiorespiratory Monitoring in Patients With Obstructive Sleep Apnea Syndrome. 80
Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism 78
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder 77
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy 76
Reactive microglia partially envelop viable neurons in prion diseases 73
Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism 72
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants 67
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 66
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants 62
Perspectives Toward the Development of Quantitative Seed Amplification Assays for α-Synuclein 61
Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival 58
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population 51
Unsuccessful transmissions of atypical genetic Creutzfeldt-Jakob disease (PRNP p.T183A-129M) in transgenic mice 48
Totale 14.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 0 0 0 0 0 0 343
2021/20221.033 55 35 48 35 113 44 16 120 63 95 212 197
2022/20231.317 117 147 62 130 119 107 54 62 233 48 153 85
2023/2024589 18 66 47 69 56 82 16 71 26 60 49 29
2024/20252.296 102 227 172 129 222 123 204 79 61 246 173 558
2025/20267.200 840 821 793 537 736 284 644 221 1.100 569 447 208
Totale 14.754